Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype

American Journal of Hypertension

Volumn 10, Issue 8, 1997, Pages 951-955

  Ohmichi, Nobuyuki ^a,b   Iwai, Naoharu ^b   Uchida, Yasukazu ^c   Shichiri, Genshou ^d   Nakamura, Yasuyuki ^b   Kinoshita, Masahiko ^b  

^a Social Insurance Shiga Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Moriyama Public Hospital   (Japan)

^d Toyosato Hospital   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensin converting enzyme inhibitor; Blood pressure; Gene

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL;

ADULT; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG BINDING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MALE; PRIORITY JOURNAL;

EID: 0030865823     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00121-0     Document Type: Article

References (24)

1. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
2. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-2628.
3. Schunkert H, Hense HW, Holmer SR, et al: Association between deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
4. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M: The genotype of the angiotensin converting enzyme gene and left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995;76:326-329.
5. Ohmichi N, Iwai N, Maeda K, et al: Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996;53:265-272.
6. Pinto YM, van Gilst WH, Kingma JH, Schunkert H: Deletion type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilatation after anterior myocardial infarction. Captopril and Thrombolysis Investigators. J Am Coll Cardiol 1995;25:1622-1626.
7. Marre M, Bernadet P, Gallois Y, et al: Relationships between angiotensin I converting enzyme polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994;43:384-388.
8. Rigat B, Hubert C, Alhenc Gelas F, et al: An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounts for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
9. Jeunemaitre X, Lifton RP, Hunt SS, et al: Absence of linkage between the angiotensin converting enzyme locus and essential hypertension. Nature Genetics 1992; 1:72-75.
10. Higashimori K, Zhao Y, Higaki J, et al: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.
11. Iwai N, Shimoike H, Ohmichi N, Kinoshita M: Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25:688-693.
12. Zee RY, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
13. Hiraga H, Oshima T, Watanabe M, et al: Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996; 27:569-572.
14. Ueda S, Elliott HL, Morton JJ, Connell JM: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-1269.
15. Lachurié ML, Azizi M, Guyene TT, et al: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-2942.
16. Iwai N, Ohmichi N, Hanai K, et al: Human SA gene locus as a candidate locus for essential hypertension. Hypertension 1994;23:375-380.
17. Bloem LJ, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin-converting enzyme activity. Hypertension 1996;27:62-66.
18. Nakai K, Itoh C, Miura Y, et al: Deletion polymorphism of the angiotensin converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202.
19. Gotoh M, Mizuno K, Hashimoto S, et al: The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients. Nippon Naibunpi Gakkai Zasshi 1985;61:619-629.
20. Johnston CI, Jackson B, McGrath B, et al: Relationship of antihypertensive effects of enarapril to serum MK-422 levels and angiotensin converting enzyme inhibition. J Hypertens 1983;1:71-75.
21. Todd GP, Chadwick IG, Higgins KS, et al: Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. Br J Clin Pharmacol 1995;39: 131-134.
22. Ueda S, Meredith PA, Morton JJ, et al: The insertion/ deletion (I/D) polymorphism of the human ACE gene differentiates the response to enalaprilat in normotensive males. J Hypertens 1996;14(suppl 1):S6.
23. Hirota Y, Kawamura S, Ohyagi A, et al: Phase I study of TA-6366 (I) - Single oral administration. Rinshou Iyaku 1992;8:507-522.
24. Hingorani AD, Jia H, Stevens PA, et al: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995;13:1602-1609.